Autres langues AstraZeneca Pharma India Limited

Actions

ASTRAZEN

INE203A01020

Marché Fermé - Bombay S.E. Autres places de cotation 12:00:54 28/06/2024			Varia. 5j.	Varia. 1 janv.
6 240 ^INR	-2,04 %		-2,12 %	+13,05 %

21/06	AstraZeneca Pharma ne trouve pas d'acheteur pour son site de production à Bangalore, en Inde	MT
01/06	Astrazeneca Pharma India Limited nomme Shikha Mirchandani Chatrath au poste de directrice - Excellence commerciale, BD et stratégie, à compter du 17 juin 2024	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

AstraZeneca Pharma Fails to Find Buyer for Manufacturing Site in Bangalore, India	21/06
Astrazeneca Pharma India Limited Appoints Shikha Mirchandani Chatrath as Director - Commercial Excellence, BD & Strategy, Effective June 17, 2024	01/06
Astrazeneca Pharma India's Net Profit Rises in Fiscal Q4	28/05
AstraZeneca Pharma India Limited Announces Resignation of Ankush Nandra as Non-Executive Director	27/05
Astrazeneca Pharma India Limited Recommends Dividend for the Financial Year 2023-24	27/05
AstraZeneca Pharma India Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	27/05
AstraZeneca Pharma India Limited Reports Earnings Results for the Full Year Ended March 31, 2024	27/05
Astrazeneca Pharma India Limited Provides Update on Olaparib 100mg and 150 mg Tablets	21/05
AstraZeneca Pharma India Limited Approves Appointment of Bhavana Agrawal as Director and Whole Time Director	08/04
AstraZeneca Pharma India Limited Appoints Vinay Sharma as Business Unit Head - Rare Disease, Effective July 1, 2024	25/03
AstraZeneca, Mankind Pharma Tie Up for Exclusive Distribution of Asthma Drug Symbicort in India	11/03
Astrazeneca Pharma India Ltd and Mankind Pharma Partner to Accelerate Access to Asthma Medicine for Patients in India	11/03
Astrazeneca Pharma India Limited Announces Board Changes	20/02
AstraZeneca Pharma India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08/02
AstraZeneca Pharma India Limited Announces Board Changes	08/02
AstraZeneca Pharma India Limited Announces Directorate Appointments	07/02
AstraZeneca Gets Indian Drug Regulator's Nod to Import Andexanet Alfa Powder for Solution for Infusion	22/01
Astrazeneca Pharma to Launch Breast Cancer Treatment Drug in India in January 2024	21/12
India's Nifty set for muted open after steep drop	21/12
Astrazeneca Pharma India Limited Appoints Hooi-Bien Chuah as Additional Director (Non-Executive)	09/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues AstraZeneca Pharma India Limited

Actions

ASTRAZEN

INE203A01020

Autres langues

Filtres